Polaris AI Pharma Corp. (KOSDAQ:041910)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,750.00
+350.00 (6.48%)
At close: Jul 10, 2026
Market Cap76.38B -30.2%
Revenue (ttm)63.94B +8.7%
Net Income989.48M -92.8%
EPS84.72 -92.8%
Shares Out 13.28M
PE Ratio67.87
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume69,760
Open5,360.00
Previous Close5,400.00
Day's Range5,360.00 - 5,790.00
52-Week Range4,110.00 - 10,200.00
Beta0.48
Analystsn/a
Price Targetn/a
Earnings Daten/a

About Polaris AI Pharma

Polaris AI Pharma Corp. engages in the manufacture and sale of pharmaceuticals products in South Korea and internationally. It also offers its products for various therapeutic categories, such as diagnostic acid, antidiabetic, anti-depressants, and cholinergic. The company was formerly known as EstechPharma Co., Ltd. and changed its name to Polaris AI Pharma Corp. in March 2024. The company was founded in 1996 and is headquartered in Hwaseong-si, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1996
Employees 161
Stock Exchange KOSDAQ
Ticker Symbol 041910
Full Company Profile